Table 4.
Drug | Dose (mg/kg) | Route | Target receptor | Action | Species | Strain | Sex | Task | Effect | References |
---|---|---|---|---|---|---|---|---|---|---|
8-OHDPAT | 0.03–0.09 | i.p. | 5-HT1A | Agonist | Rat | Wistar Han | M | MWM | No effect | Riekkinen et al., 1994 |
8-OHDPAT | 0.1, 0.3 | s.c. | 5-HT1A | Agonist | Rat | Wistar | M | MWM | Impairment | Meijer et al., 1998 |
8-OHDPAT | 0.25 | i.p. | 5-HT1A | Agonist | Rat | Sprague Dawley | M | Mod MWM | Impairment | Kant et al., 1998 |
8-OHDPAT | 2 | i.p. | 5-HT1A | Agonist | Rat | Sprague Dawley | M | SA | Impairment | Seibell et al., 2003 |
8-OHDPAT | 0.125–2 | i.p. | 5-HT1A | Agonist | Rat | Sprague Dawley | M | SA | Impairment | Ulloa et al., 2004 |
8-OHDPAT | 0.125–2 | i.p. | 5-HT1A | Agonist | Rat | Sprague Dawley | F | SA | No effect | Ulloa et al., 2004 |
8-OHDPAT | 0.25–0.5 | i.p. | 5-HT1A | Agonist | Rat | Wistar | M | Auto | Impairment | Meneses, 2007 |
8-OHDPAT | 1 | i.p. | 5-HT1A | Agonist | Rat | Wistar | M | Auto | No effect | Meneses, 2007 |
8-OHDPAT | 0.031–0.25 | i.p. | 5-HT1A | Agonist | Rat | Wistar | M | Auto | Improvement | Meneses and Hong, 1999 |
8-OHDPAT | 0.062 | i.p. | 5-HT1A | Agonist | Rat | Wistar | M | Auto | Improvement | Meneses et al., 1997 |
8-OHDPAT | 1 | i.p. | 5-HT1A | Agonist | Rat | Wistar | M | Auto | No effect | Meneses and Hong, 1999 |
8-OHDPAT | 0.1–1 | s.c. | 5-HT1A | Agonist | Rat | Wistar | M | NOR | Impairment | Pitsikas et al., 2005 |
Buspirone | 10 | i.p. | 5-HT1A | Agonist | Rat | Sprague Dawley | M | Mod MWM | Impairment | Kant et al., 1998 |
S15535 | 0.16–10 | s.c. | 5-HT1A | Partial agonist | Rat | Wistar | M | SR | Improvement | Millan et al., 2004 |
S15535 | 0.16–0.63 | s.c. | 5-HT1A | Partial agonist | Mouse | C57BL/6 | M | DNMTS | Improvement | Millan et al., 2004 |
S15535 | 1.25–5 | p.o. | 5-HT1A | Partial agonist | Rat | old Wistar | M | DNMTS | Improvement | Millan et al., 2004 |
WAY100635 | 0.3–1 | i.p. | 5-HT1A | Antagonist | Rat | CD-COBS | M | NOR | No effect | Pitsikas et al., 2003 |
WAY100635 | 0.3–1 | s.c. | 5-HT1A | Antagonist | Rat | Wistar | M | NOR | No effect | Pitsikas et al., 2005 |
WAY100635 | 0.001–1 | i.p. | 5-HT1A | Antagonist | Rat | Wistar | M | Auto | No effect | Meneses and Hong, 1999 |
WAY100135 | 5–20 | i.p. | 5-HT1A | Antagonist | Rat | Wistar | M | Auto | No effect | Meneses and Hong, 1999 |
DOI | 1 | i.p. | 5-HT2A/2C | Agonist | Rat | Sprague Dawley | M | SA | No effect | Seibell et al., 2003 |
DOI | 0.1–0.25 | i.p. | 5-HT2A/2C | Agonist | Rat | Sprague Dawley | M | Mod MWM | No effect | Kant et al., 1998 |
DOI | 0.1–1 | i.p. | 5-HT2A/2C | Agonist | Rat | Wistar | M | Auto | Impairment | Meneses, 2007 |
DOI | 0.1 | i.p. | 5-HT2A/2C | Agonist | Rat | Wistar | M | Auto | Improvement | Meneses et al., 1997 |
ketanserin | 0.001 | i.p. | 5-HT2 | Antagonist | Rat | Wistar | M | Auto | Improvement | Meneses et al., 1997 |
M100907 | 0.08 | i.p. | 5-HT2A | Antagonist | Rat | Wistar | M | DALT | No effect | Papakosta et al., 2013 |
M100907 | 0.1–3 | i.p. | 5-HT2A | Antagonist | Rat | Wistar | M | Auto | No effect | Meneses et al., 1997 |
SB242084 | 0.5 | i.p. | 5-HT2C | Antagonist | Rat | Wistar | M | DALT | No effect | Papakosta et al., 2013 |
Auto, autoshaping; DALT, delayed alternation; DNMTS, delayed non-match to sample; F, female; M, male; MWM, Morris water maze; Mod, modified; NOR, novel object recognition; SA, spontaneous alternation; SR, social recognition.